T-cell surface glycoprotein CD3 complex (CD3) (CD3)

The CD3 complex is a critical multi-subunit protein assembly found on the surface of all mature T lymphocytes, consisting of four distinct polypeptide chains: CD3-gamma, CD3-delta, CD3-epsilon, and CD3-zeta (UniProt: P07766, P04234, P09693, P20963). It non-covalently associates with the T-cell receptor (TCR) to form the TCR-CD3 complex, which is responsible for transducing signals into the T-cell upon antigen recognition by the TCR (StatPearls: T-cell receptors). This signaling cascade is essential for T-cell activation, proliferation, and the execution of effector functions in the adaptive immune response. In therapeutic contexts, CD3 is a primary target for bispecific T-cell engagers (BiTEs) and other multispecific antibodies designed to bridge T-cells to malignant cells, thereby inducing targeted tumor lysis (Nature Reviews Drug Discovery). Conversely, monoclonal antibodies against CD3 have been utilized as potent immunosuppressive agents to prevent organ transplant rejection and treat autoimmune conditions like Type 1 diabetes by modulating or depleting the T-cell population (DrugBank).

Other names

T3 complexT-cell receptor-CD3 complexCD3 antigenT-cell co-receptor

The CD3 complex acts as the signal transduction component of the T-cell receptor (TCR). Therapeutic antibodies targeting CD3 function through several mechanisms: 1) T-cell redirection, where bispecific antibodies (e.g., BiTEs) bind CD3 and a tumor antigen to induce MHC-independent T-cell cytotoxicity; 2) Immunosuppression, where antibodies like muromonab-CD3 cause TCR internalization or T-cell depletion; and 3) Immune modulation, where non-Fc-binding antibodies like teplizumab induce partial T-cell signaling leading to anergy or the induction of regulatory T-cells (Tregs) (Nature Reviews Drug Discovery; DrugBank).